Ebola laboratory tests: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) |
Joao Silva (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{MJM}}; {{GRN}} | {{CMG}}; {{AE}} {{MJM}}; {{GRN}} | ||
==Overview== | ==Overview== | ||
[[Ebola]] infection is associated with nonspecific laboratory abnormalities including alterations in the [[white blood cell]] count, [[blood chemistry tests]] and [[liver function tests]], all of which may contribute to a disruption in the [[thrombosis|clotting]] process and bleeding. | [[Ebola]] infection is associated with nonspecific laboratory abnormalities including alterations in the [[white blood cell]] count, [[blood chemistry tests]] and [[liver function tests]], all of which may contribute to a disruption in the [[thrombosis|clotting]] process and [[bleeding]]. | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
Revision as of 22:07, 17 July 2014
|
Ebola Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Postmortem Care |
|
Case Studies |
|
Ebola laboratory tests On the Web |
|
American Roentgen Ray Society Images of Ebola laboratory tests |
|
Risk calculators and risk factors for Ebola laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Michael Maddaleni, B.S.; Guillermo Rodriguez Nava, M.D. [2]
Overview
Ebola infection is associated with nonspecific laboratory abnormalities including alterations in the white blood cell count, blood chemistry tests and liver function tests, all of which may contribute to a disruption in the clotting process and bleeding.
Laboratory Findings
The table below displays the nonspecific laboratory abnormalities associated with Ebola infection, including:[1]
| Test | Findings |
|---|---|
| White blood cell count | Leucopenia Lymphopenia Neutrophilia |
| Blood smear | Left shift Atypical lymphocytes |
| Coagulation | Consumption of clotting factors Increased concentrations of fibrin degradation products |
| Liver function tests | Raised aspartate aminotransferase Raised alanine aminotransferase Extended prothrombin time Extended partial thromboplastin time |
| Proteins | Hyperproteinemia |
| Urinalysis | Proteinuria |
References
- ↑ Feldmann H, Geisbert TW (2011). "Ebola haemorrhagic fever". Lancet. 377 (9768): 849–62. doi:10.1016/S0140-6736(10)60667-8. PMC 3406178. PMID 21084112.